Japanese Company Kyowa Hakko Kirin to Buy ProStrakan Group for £292 Million

Published: Feb 22, 2011

WSJ -- Japanese pharmaceutical company Kyowa Hakko Kirin Co. agreed to buy Scotland's Pro Strakan Group PLC for £292 million ($474 million) in an effort to expand its cancer-drug business outside Japan.

Back to news